TERMIS 2021 | Tissue engineered corneas as a replacement for transplantation

Issues relating to supply and storage has resulted in corneal transplantation to be out of reach for many developing countries. Mark Daniell, MBBS, MS, FRANZCO, FRACS, Royal Victorian Eye and Ear Hospital & Centre for Eye Research Australia, Melbourne, Australia, describes research on the development of tissue engineered corneas. In vivo expansion of the endothelial layer, which does not naturally replicate, ensure a sustainable supply of corneas to patients and hydrogel scaffolds enable a biocompatible and biodegradable scaffold on which the tissue can grow on. This interview took place at 6th world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).